2-Bromo-1-(bromomethyl)-3-iodobenzene, 95.0%, 250mg

(R)-3-(1-aminoethyl)-5-(trifluoromethyl)aniline hydrochloride, 98%, 1g

2-(4-((2-Chlorothiazol-5-yl)methoxy)phenyl)acetonitrile, 95+%, 1g

1-(4-Amino-3-ethoxyphenyl)piperidin-4-ol, 97%, 1g

2-(4-bromophenyl)-1,4-dihydroquinazolin-4-one, 97%, 5g

4-Octyl-3-thiosemicarbazide, 97%, 5g

Benzene, 1,1'-thiobis[4-methoxy-, 98%, 250mg

2-Amino-2-(4-methoxyphenyl)acetic acid, 95.0%, 5g

Tripropylene Glycol Diacrylate (stabilized with MEHQ)>90.0%(GC)100g

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 100, 500 ml, 130 mm, 1 Piece

(E)-3-(2-Methoxypyridin-3-yl)acrylic acid, 98%, 25g

1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), min. 98%, for synthesis, 25 ml, glass packaging

N-(Chloroacetyl)morpholine, 97.0%, 5g